Millipede

Millipede is a medical technology company specializing in the development of a transcatheter annuloplasty ring system for the treatment of severe mitral regurgitation (MR). The company's flagship product, the IRIS Complete Annuloplasty Ring, is designed to restore the mitral valve to its pre-dilated shape and size, mimicking the gold standard of surgical repair through a less invasive percutaneous approach. Millipede's technology is unique in its ability to be adjusted and repositioned during the procedure to ensure optimal results. In 2019, the company was acquired by Boston Scientific to bolster its structural heart portfolio. The IRIS system is delivered via a transseptal catheter and is intended to provide a more durable solution than existing repair techniques.